ConductScience.org, home

Paper34880490

The emergence, genomic diversity and global spread of SARS-CoV-2.

Li J and 3 others. Nature, 2021. Cited by 322 papers, by iCite.

Cite this record

ConductScience Library. The emergence, genomic diversity and global spread of SARS-CoV-2. Papers, record 34880490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34880490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The emergence, genomic diversity and global spread of SARS-CoV-2.
PubMed
Journal
Nature
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
322
iCite
Relative citation ratio, by iCite
16.9
iCite
Revised in PubMed
2026-10-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Genome, ViralMajor topic
InternationalityMajor topic
SARS-CoV-2Major topic
Animals
Humans
Mink
Molecular Epidemiology
Phylogeny
Spike Glycoprotein, Coronavirus

Source PubMed

Download CSV of topics

References141

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133235813Temporal signal and the phylodynamic threshold of SARS-CoV-2.Virus Evol2020https://conductscience.org/library/papers/33235813PubMed
232822564Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.Lancet2020https://conductscience.org/library/papers/32822564PubMed
333852911Antibody evasion by the P.1 strain of SARS-CoV-2.Cell2021https://conductscience.org/library/papers/33852911PubMed
431986261A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.Lancet2020https://conductscience.org/library/papers/31986261PubMed
532015507A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature2020https://conductscience.org/library/papers/32015507PubMed
632075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
734192736Untangling introductions and persistence in COVID-19 resurgence in Europe.Nature2021https://conductscience.org/library/papers/34192736PubMed
832380510Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.Nature2020https://conductscience.org/library/papers/32380510PubMed
931985790Potential for global spread of a novel coronavirus from China.J Travel Med2020https://conductscience.org/library/papers/31985790PubMed
1033414196Viral evolution may herald new pandemic phase.Science2021https://conductscience.org/library/papers/33414196PubMed
1132007145Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet2020https://conductscience.org/library/papers/32007145PubMed
1233094347Uncovering two phases of early intercontinental COVID-19 transmission dynamics.J Travel Med2020https://conductscience.org/library/papers/33094347PubMed
1333243994SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.Nat Commun2020https://conductscience.org/library/papers/33243994PubMed
1433106671Spike mutation D614G alters SARS-CoV-2 fitness.Nature2021https://conductscience.org/library/papers/33106671PubMed
1534594901Controlling COVID-19 Transmission due to Contaminated Imported Frozen Food and Food Packaging.China CDC Wkly2021https://conductscience.org/library/papers/34594901PubMed
1631995857Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.N Engl J Med2020https://conductscience.org/library/papers/31995857PubMed
1732234804An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China.Science2020https://conductscience.org/library/papers/32234804PubMed
1833323424Inferring the effectiveness of government interventions against COVID-19.Science2021https://conductscience.org/library/papers/33323424PubMed
1933743213Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021https://conductscience.org/library/papers/33743213PubMed
2033259154Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.N Engl J Med2020https://conductscience.org/library/papers/33259154PubMed

See all 141 referencesDownload CSV of references

Cited by254

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.

PMIDTitleJournalYearIn PapersSource
42931196Genomic Surveillance of Respiratory Pathogens: From Molecular Detection to Precision Infection Control.Pathogens2026https://conductscience.org/library/papers/42931196PubMed
42912463MERS-CoV-3D: integrating whole-genome variation, proteome mapping, and structural annotation of MERS-CoV mutations.Database (Oxford)2026https://conductscience.org/library/papers/42912463PubMed
42903912A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif.Hlife2024https://conductscience.org/library/papers/42903912PubMed
42870688Overcoming Detection Lag in a Cryptic Panzootic: Chytrid Invasion Linked to Historically Enigmatic Amphibian Declines in the Brazilian Atlantic Forest.Mol Ecol2026https://conductscience.org/library/papers/42870688PubMed
42769501Genetic factors associated with COVID-19 severity and mortality: TYK2 and NOTCH4.Biomed Rep2026https://conductscience.org/library/papers/42769501PubMed
42707259A viral-vectored multipathogen vaccine platform based on replication-competent vaccinia virus and adeno-associated virus.Front Immunol2026https://conductscience.org/library/papers/42707259PubMed
42587116Shared principles of human and bacterial antiviral immunity.Nature2026https://conductscience.org/library/papers/42587116PubMed
42506641Evaluating Memory B Cell Cross-Reactivity Between Ancestral and Future SARS-CoV-2 Variants-Evidence for Original Antigenic Sin.Vaccines (Basel)2026https://conductscience.org/library/papers/42506641PubMed
42390252Healthcare-facility-based SARS-CoV-2 genomic surveillance in Brazil: experience from the global action in healthcare network.Microbiol Spectr2026https://conductscience.org/library/papers/42390252PubMed
42378129Characterization of recombinant genomes of the omicron variant of SARS-CoV-2 between 2022 and 2023 in the department of Antioquia, ColombiaBiomedica2026https://conductscience.org/library/papers/42378129PubMed
42376297Lung organoids for respiratory diseases: overcoming translational hurdles in drug discovery and safety assessment.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42376297PubMed
42357598Interactomics of SARS-CoV-2 Macrodomain 1 Reveals Putative Clients of ADP-Ribosyl Hydrolase Activity.Viruses2026https://conductscience.org/library/papers/42357598PubMed
42169206
Impact of the COVID-19 pandemic on diagnosis, and healthcare utilization, among patients with cancer (lung, breast, and pancreas) and cardiovascular diseases (HF, AF, hypertensive, and chronic ischemic heart disease) in Germany: two systematic reviews.
Syst Rev2026https://conductscience.org/library/papers/42169206PubMed
42135777The adult nasal mucosa is defined by distinct immune profiles that modulate in-vitro SARS-CoV-2 infection.Respir Res2026https://conductscience.org/library/papers/42135777PubMed
42094075Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.Transbound Emerg Dis2026https://conductscience.org/library/papers/42094075PubMed
42043203Post-Pandemic Neutralizing Antibody Responses to SARS-CoV-2 D614G Variant in Rural and Urban Ghana.Viruses2026https://conductscience.org/library/papers/42043203PubMed
41962740Genomic-epidemiological analysis of 15 million SARS-CoV-2 genomes reveals accelerated fitness gain of JN.1 lineage.Virol Sin2026https://conductscience.org/library/papers/41962740PubMed
41941113Simultaneous detection of SARS-CoV-2 proteins and nucleic acids by coupling PNIPAM with circle-to-circle amplification.Anal Sci2026https://conductscience.org/library/papers/41941113PubMed
41893817Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice.Vaccines (Basel)2026https://conductscience.org/library/papers/41893817PubMed
41851107Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.Cell Death Discov2026https://conductscience.org/library/papers/41851107PubMed

See all 254 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34880490

GET https://conductscience.org/api/papers/v1/34880490/references?page=2